arrow
A

Abraham Rutgers

University of Groningen
H指数:31
被引数:3,865

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis

ANCA相关性血管炎在诊断、分类和预后方面的挑战

2025-10-160
PRE
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

美国风湿病学会关于VEXAS诊断与管理的指南声明,由国际VEXAS工作组专家委员会制定

2025-08-110
OAAI
IMMUNE CHECKPOINT INHIBITOR-MEDIATED POLYMYALGIA RHEUMATICA VERSUS PRIMARY POLYMYALGIA RHEUMATICA: COMPARISON OF DISEASE CHARACTERISTICS AND TREATMENT REQUIREMENT

免疫检查点抑制剂介导的皮肌炎与原发性皮肌炎:疾病特征和治疗需求的比较

2024-06-010
PRE
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program

IEI患者新型冠状病毒肺炎加强疫苗接种的免疫原性及其开始新型冠状病毒肺炎疫苗接种计划后一年的临床随访

2024-04-184
OAAI
The link between the early surgery-induced inflammatory response and postoperative cognitive dysfunction in older patients

早期手术诱发的炎症反应与老年患者术后认知功能障碍的关系

2024-03-223
OA
Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis

靶向b细胞中的nf-κb信号传导作为ANCA相关血管炎的潜在新治疗方式

2024-01-013
OA
Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort

国家DADA2队列的临床症状,实验室参数和长期随访

2023-06-056
OAAI
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity

mRNA-1273新型冠状病毒肺炎疫苗接种后6个月的免疫反应以及先天性免疫缺陷患者第三次疫苗接种的影响

2023-05-2610
OAAI
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

免疫介导的炎性疾病患者的原发性SARS-CoV-2感染: 长期体液免疫反应及其对疾病活动的影响

2023-05-175
OAAI